ESALF
:US OTC

Add to watchlist
$59.72
Last updated:12/02/2021
ESALF: US OTC
$59.72
Eisai Co. Ltd

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-ins…

Dividend yield
2.41%
$1.44 anually
P/E ratio
30.93x
vs. 45.45x forward
Payout ratio
74.65%
Yearly
CASH payout ratio
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
past 12 months
Become our supporter to unlock all data!
ESALF dividends
Create free account to unlock
Company results
Qtr
Ann
Fundamentals
2018
2019
2020
2021
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
Create free account to unlock
Cashflow
Sum up money going in and out company
Create free account to unlock
Total liabilities
All combined debts and obligations
Create free account to unlock
Company profile
CEO
Mr. Haruo Naito
Market capitalization
Large (17.82B)